annual EBIT:
-$568.20M+$639.54M(+52.95%)Summary
- As of today (June 22, 2025), ONC annual earnings before interest & taxes is -$568.20 million, with the most recent change of +$639.54 million (+52.95%) on December 31, 2024.
- During the last 3 years, ONC annual EBIT has risen by +$870.54 million (+60.51%).
- ONC annual EBIT is now -11889.85% below its all-time high of -$4.74 million, reached on December 1, 2013.
Performance
ONC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$11.10M+$90.53M(+113.98%)Summary
- As of today (June 22, 2025), ONC quarterly earnings before interest & taxes is $11.10 million, with the most recent change of +$90.53 million (+113.98%) on March 1, 2025.
- Over the past year, ONC quarterly EBIT has increased by +$272.45 million (+104.25%).
- ONC quarterly EBIT is now -90.34% below its all-time high of $114.91 million, reached on September 1, 2017.
Performance
ONC quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$295.75M+$272.45M(+47.95%)Summary
- As of today (June 22, 2025), ONC TTM earnings before interest & taxes is -$295.75 million, with the most recent change of +$272.45 million (+47.95%) on March 1, 2025.
- Over the past year, ONC TTM EBIT has increased by +$802.08 million (+73.06%).
- ONC TTM EBIT is now -3462.81% below its all-time high of -$8.30 million, reached on September 1, 2014.
Performance
ONC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ONC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.0% | +104.3% | +73.1% |
| 3 y3 years | +60.5% | +102.5% | +84.8% |
| 5 y5 years | +40.8% | +103.0% | +79.4% |
ONC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.3% | at high | +102.4% | at high | +84.6% |
| 5 y | 5-year | at high | +68.3% | -84.2% | +101.9% | at high | +84.8% |
| alltime | all time | <-9999.0% | +68.3% | -90.3% | +101.9% | -3462.8% | +84.8% |
ONC EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $11.10M(-114.0%) | -$295.75M(-47.9%) |
| Dec 2024 | -$568.20M(-53.0%) | -$79.42M(-34.0%) | -$568.20M(-34.9%) |
| Sep 2024 | - | -$120.27M(+12.2%) | -$872.57M(-1.5%) |
| Jun 2024 | - | -$107.16M(-59.0%) | -$886.27M(-19.3%) |
| Mar 2024 | - | -$261.35M(-31.9%) | -$1.10B(-9.1%) |
| Dec 2023 | -$1.21B(-32.5%) | -$383.80M(+186.5%) | -$1.21B(-6.6%) |
| Sep 2023 | - | -$133.97M(-58.0%) | -$1.29B(-19.1%) |
| Jun 2023 | - | -$318.71M(-14.2%) | -$1.60B(-7.0%) |
| Mar 2023 | - | -$371.26M(-20.8%) | -$1.72B(-4.0%) |
| Dec 2022 | -$1.79B(+24.4%) | - | - |
| Dec 2022 | - | -$468.62M(+6.9%) | -$1.79B(-5.4%) |
| Sep 2022 | - | -$438.36M(-0.2%) | -$1.89B(-1.3%) |
| Jun 2022 | - | -$439.40M(-0.9%) | -$1.92B(-1.8%) |
| Mar 2022 | - | -$443.29M(-22.5%) | -$1.95B(+35.7%) |
| Dec 2021 | -$1.44B(-13.2%) | -$571.74M(+23.7%) | -$1.44B(+6.4%) |
| Sep 2021 | - | -$462.32M(-2.6%) | -$1.35B(+1.7%) |
| Jun 2021 | - | -$474.84M(-776.7%) | -$1.33B(+9.6%) |
| Mar 2021 | - | $70.17M(-114.5%) | -$1.21B(-26.8%) |
| Dec 2020 | -$1.66B(+72.7%) | -$484.91M(+10.2%) | -$1.66B(+6.2%) |
| Sep 2020 | - | -$440.14M(+22.6%) | -$1.56B(+8.9%) |
| Jun 2020 | - | -$358.88M(-4.0%) | -$1.43B(+23.5%) |
| Mar 2020 | - | -$373.76M(-3.7%) | -$1.16B(+20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$959.89M(+36.0%) | -$388.04M(+24.3%) | -$959.89M(+12.6%) |
| Sep 2019 | - | -$312.27M(+263.8%) | -$852.66M(+23.3%) |
| Jun 2019 | - | -$85.83M(-50.6%) | -$691.50M(-10.0%) |
| Mar 2019 | - | -$173.75M(-38.1%) | -$768.72M(+8.9%) |
| Dec 2018 | -$705.77M(+616.8%) | -$280.81M(+85.8%) | -$705.77M(+33.5%) |
| Sep 2018 | - | -$151.10M(-7.3%) | -$528.76M(+101.2%) |
| Jun 2018 | - | -$163.05M(+47.1%) | -$262.75M(+66.6%) |
| Mar 2018 | - | -$110.81M(+6.8%) | -$157.72M(+60.2%) |
| Dec 2017 | -$98.46M(-15.9%) | -$103.80M(-190.3%) | -$98.46M(+208.4%) |
| Sep 2017 | - | $114.91M(-298.0%) | -$31.93M(-82.4%) |
| Jun 2017 | - | -$58.02M(+12.6%) | -$181.66M(+22.5%) |
| Mar 2017 | - | -$51.54M(+38.3%) | -$148.27M(+26.7%) |
| Dec 2016 | -$117.06M(+106.3%) | -$37.27M(+7.0%) | -$117.06M(+8.9%) |
| Sep 2016 | - | -$34.83M(+41.4%) | -$107.52M(+24.5%) |
| Jun 2016 | - | -$24.63M(+21.1%) | -$86.39M(+28.7%) |
| Mar 2016 | - | -$20.33M(-26.7%) | -$67.13M(+18.3%) |
| Dec 2015 | -$56.74M(+260.1%) | -$27.73M(+102.4%) | -$56.74M(+70.9%) |
| Sep 2015 | - | -$13.70M(+155.2%) | -$33.20M(+19.4%) |
| Jun 2015 | - | -$5.37M(-46.0%) | -$27.80M(+23.9%) |
| Mar 2015 | - | -$9.95M(+137.5%) | -$22.43M(+79.6%) |
| Dec 2014 | -$15.76M(+232.5%) | -$4.19M(-49.5%) | -$12.49M(+50.5%) |
| Sep 2014 | - | -$8.30M | -$8.30M |
| Dec 2013 | -$4.74M | - | - |
FAQ
- What is BeOne Medicines annual earnings before interest & taxes?
- What is the all time high annual EBIT for BeOne Medicines?
- What is BeOne Medicines annual EBIT year-on-year change?
- What is BeOne Medicines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BeOne Medicines?
- What is BeOne Medicines quarterly EBIT year-on-year change?
- What is BeOne Medicines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BeOne Medicines?
- What is BeOne Medicines TTM EBIT year-on-year change?
What is BeOne Medicines annual earnings before interest & taxes?
The current annual EBIT of ONC is -$568.20M
What is the all time high annual EBIT for BeOne Medicines?
BeOne Medicines all-time high annual earnings before interest & taxes is -$4.74M
What is BeOne Medicines annual EBIT year-on-year change?
Over the past year, ONC annual earnings before interest & taxes has changed by +$639.54M (+52.95%)
What is BeOne Medicines quarterly earnings before interest & taxes?
The current quarterly EBIT of ONC is $11.10M
What is the all time high quarterly EBIT for BeOne Medicines?
BeOne Medicines all-time high quarterly earnings before interest & taxes is $114.91M
What is BeOne Medicines quarterly EBIT year-on-year change?
Over the past year, ONC quarterly earnings before interest & taxes has changed by +$272.45M (+104.25%)
What is BeOne Medicines TTM earnings before interest & taxes?
The current TTM EBIT of ONC is -$295.75M
What is the all time high TTM EBIT for BeOne Medicines?
BeOne Medicines all-time high TTM earnings before interest & taxes is -$8.30M
What is BeOne Medicines TTM EBIT year-on-year change?
Over the past year, ONC TTM earnings before interest & taxes has changed by +$802.08M (+73.06%)